GGrantIndex
Sort

40,608 grants matching prostate cancer

High speed automated intraoperative microscopy of the prostate circumference to ensure tumor-free margins in radical prostatectomy

$355,935
Jonathan Quincy Brown · Tulane University Of Louisiana · R01 · FY2020 · CA

Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors

$355,916
Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2023 · CA

Role of JMJD1A modifications in castration resistance of prostate cancer

$355,855
Jianfei Qi · University Of Maryland Baltimore · R01 · FY2020 · CA

Genetic and genomic determinants of homologous recombination repair deficiency as treatment selection markers for lethal prostate cancer

$355,850
Jun Luo · Johns Hopkins University · R01 · FY2024 · CA

Immunogenomic determinants of response and resistance to neoadjuvant anti-PD-1 in resectable NSCLC

$355,850
Kellie Nicole Smith · Johns Hopkins University · R37 · FY2024 · CA

Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.

$355,850
Eneda Toska · Johns Hopkins University · R01 · FY2024 · CA

Inhibition of novel molecular targets of prostaglandin formation for antitumor ac

$355,842
Emmanuelle Joelle Meuillet · University Of Arizona · R01 · FY2010 · CA

P13K/PTEN/Akt (PKB), Signaling and genesis of cancer

$355,841
University Of Illinois At Chicago · R01 · FY2002 · CA

P13K/PTEN/Akt (PKB), Signaling and genesis of cancer

$355,841
University Of Illinois At Chicago · R01 · FY2005 · CA

P13K/PTEN/Akt (PKB), Signaling and genesis of cancer

$355,841
University Of Illinois At Chicago · R01 · FY2003 · CA

P13K/PTEN/Akt (PKB), Signaling and genesis of cancer

$355,841
University Of Illinois At Chicago · R01 · FY2004 · CA

A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer

$355,819
Don X Nguyen · Yale University · R01 · FY2016 · CA

CANCER AWARENESS NETWORK FOR IMMIGRANT MINORITY POPULATI

$355,790
New York University School Of Medicine · U01 · FY2000 · CA

Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription

$355,773
Victor Jin · University Of Texas Hlth Science Center · U54 · FY2019 · CA

MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE

$355,772
Lieping Chen · Yale University · R01 · FY2011 · CA

Project 2 - Clinical translation

$355,767
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA

Targeting androgen receptor nuclear localization in prostate cancer

$355,729
Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA

GPCR - Linked RhoGEFs in Tumor Growth and Metastasis

$355,725
John J G Tesmer · Purdue University · R01 · FY2021 · CA

GPCR - Linked RhoGEFs in Tumor Growth and Metastasis

$355,725
John J G Tesmer · Purdue University · R01 · FY2020 · CA

Chromosome Instability Drives Metal-Induced Lung Cancer

$355,720
John Pierce Wise · University Of Louisville · R35 · FY2023 · ES

Clinical Pharmacogenetics

$355,712
William D Figg · Basic Sciences · Z01 · FY2007 · CA

Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer

$355,712
William D Figg · Basic Sciences · Z01 · FY2007 · CA

Development of Angiogenesis Inhibitors

$355,712
William D Figg · Clinical Sciences · Z01 · FY2007 · CA

Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma

$355,706
Nicholas K Foreman · University Of Colorado Denver · R01 · FY2021 · CA

Targeting CD133 for imaging and therapy in prostate cancer

$355,706
Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2022 · CA